Regulation 31 Amendment of Schedule 1I1
United Kingdom
Schedule 1 (further provisions for classification of medicinal products) is amended as follows.
In Part 1 M1 (descriptions of certain medicinal products to be available only on prescription), in paragraph 1—
omit “and” at the end of sub-paragraph (f);
insert “ ; and ” at the end of sub-paragraph (g); and
after sub-paragraph (g) insert—
“(h)a product which is authorised by the licensing authority on a temporary basis under regulation 174, in circumstances where the licensing authority has attached a condition to that authorisation to the effect that, for the duration of the temporary authorisation, the product is classified as a prescription only medicine.”.
In Part 2 M2 (descriptions of certain medicinal products to be available only from a pharmacy), in paragraph 3—
insert “ ; and ” at the end of sub-paragraph (c); and
after sub-paragraph (c) insert—
“(d)a product which is authorised by the licensing authority on a temporary basis under regulation 174, in circumstances where the licensing authority has attached a condition to that authorisation to the effect that, for the duration of the temporary authorisation, it is only to be available from a pharmacy.”.
Annotations
Marginal citations
- M1
Part 1 has been amended by S.I. 2014/490 and 2019/775.
- M2
Part 2 has been amended by S.I. 2019/775.
Commencement
- I1
Reg. 31 in force at 6.11.2020, see reg. 1(2)